immunomix.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.immunomix.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home - Immunomic
Description Search for: Pipeline Partnerships Clinical Trials Glioblastoma Multiforme Merkel Cell Carcinoma Team Careers Media Contact Us Pipeline Partnerships Clinic
Keywords N/A
Server Information
WebSite immunomix faviconimmunomix.com
Host IP 104.207.234.88
Location United States
Related Websites
Site Rank
More to Explore
immunomix.com Valuation
US$6,552,937
Last updated: 2023-05-07 01:26:44

immunomix.com has Semrush global rank of 1,615,200. immunomix.com has an estimated worth of US$ 6,552,937, based on its estimated Ads revenue. immunomix.com receives approximately 756,109 unique visitors each day. Its web server is located in United States, with IP address 104.207.234.88. According to SiteAdvisor, immunomix.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$6,552,937
Daily Ads Revenue US$6,049
Monthly Ads Revenue US$181,466
Yearly Ads Revenue US$2,177,592
Daily Unique Visitors 50,408
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
immunomix.com. A 7199 IP: 104.207.234.88
immunomix.com. NS 43200 NS Record: dns1134-2.nexcess.net.
immunomix.com. NS 43200 NS Record: dns1134-1.nexcess.net.
immunomix.com. MX 43200 MX Record: 10 spamwall.cflsdata.com.
immunomix.com. TXT 3600 TXT Record: v=spf1 include:spf.smtp2go.com ?all
immunomix.com. TXT 3600 TXT Record: MS=ms50621073
HtmlToTextCheckTime:2023-05-07 01:26:44
Search for: Pipeline Partnerships Clinical Trials Glioblastoma Multiforme Merkel Cell Carcinoma Team Careers Media Contact Us Pipeline Partnerships Clinical Trials Glioblastoma Multiforme Merkel Cell Carcinoma Team Careers Media Contact Us Home Our Company Immunomic Therapeutics, Inc. (ITI) is a privately held, clinical stage biotechnology company pioneering the development of vaccines through its proprietary technology platform, UNiversal Intracellular Targeted Expression (UNITE ® ), which is designed to utilize the body’s natural biochemistry to develop vaccines that generate broad immune responses Read More Our Focus ITI is primarily focused on applying the UNITE ® platform to oncology, where it could potentially have broad applications, including antigen-derived antibodies as biologics. The Company has built a pipeline leveraging UNITE ® with programs in oncology, animal health, infectious disease, and allergy. Read More Our Technology ITI’s investigational UNITE ® platform,
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 01:35:01 GMT
Server: Apache
Location: https://www.immunomix.com/
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Wed, 27 Oct 2021 01:35:01 GMT
Server: Apache
X-Pingback: https://www.immunomix.com/xmlrpc.php
Link: ; rel="https://api.w.org/"
Link: ; rel="alternate"; type="application/json"
Link: ; rel=shortlink
Content-Type: text/html; charset=UTF-8
immunomix.com Whois Information
Domain Name: IMMUNOMIX.COM
Registry Domain ID: 612689790_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.webhero.com
Registrar URL: http://webhero.com
Updated Date: 2017-02-26T20:25:12Z
Creation Date: 2006-09-29T14:56:01Z
Registry Expiry Date: 2021-09-29T14:56:01Z
Registrar: Webhero, Inc.
Registrar IANA ID: 112
Registrar Abuse Contact Email: abuse@webhero.com
Registrar Abuse Contact Phone: 405-753-9300
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS1134-1.NEXCESS.NET
Name Server: DNS1134-2.NEXCESS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T00:10:41Z <<<